Moderna Just Made a $700,000 Mistake
Moderna (NASDAQ: MRNA) is having a terrific year, raking in profits and generating plenty of cash due to its COVID-19 vaccine. However, that doesn't mean it has money to waste. As its business grows and the company plans for a post-COVID future, it needs to make smart decisions with its money.
It recently made a blunder that cost it a whopping $700,000. And the worst part of all: The company got nothing from it but a painful learning experience.
Image source: Getty Images.
Source Fool.com
